Medpace Holdings (MEDP) Receivables (2015 - 2026)

Medpace Holdings has reported Receivables for 12 years, with the latest figure at $418.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 37.51% year-over-year to $418.8 million; the trailing twelve-month figure through Mar 2026 stood at $418.8 million (up 37.51% YoY), and the FY2025 full-year result was $427.4 million, up 41.63% from the prior year.
• Receivables for Q1 2026 stood at $418.8 million, down from $427.4 million in the prior quarter.
• The five-year high for Receivables was $427.4 million in Q4 2025, with the low at $225.9 million in Q2 2022.
• Historically, Receivables has averaged $321.5 million across 5 years, with a median of $306.7 million in 2023.
• Annual changes were most pronounced in 2022 — Receivables surged 55.73% — and 2024, when it fell 5.95%.
• Medpace Holdings' Receivables stood at $293.8 million in 2022, then advanced by 9.21% to $320.9 million in 2023, then retreated by 5.95% to $301.8 million in 2024, then soared by 41.63% to $427.4 million in 2025, then fell by 2.02% to $418.8 million in 2026.
• The last three Receivables figures came in at $418.8 million (Q1 2026), $427.4 million (Q4 2025), and $383.8 million (Q3 2025), per Business Quant data.